Geron Corp (GERN) Reports In-Line Q1 EPS
Tweet
Share
E-mailGet Alerts GERN Hot Sheet
Price: $1.51 -3.82%
Revenue Growth %: +28.6%
Financial Fact:
Interest and other income: 293K
Today's EPS Names:
VIVO, BIOX, PMCB, More
Revenue Growth %: +28.6%
Financial Fact:
Interest and other income: 293K
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Geron Corp (NASDAQ: GERN) reported Q1 EPS of ($0.05), in-line with the analyst estimate of ($0.05). Revenue for the quarter came in at $537 thousand versus the consensus estimate of $180 thousand.
For earnings history and earnings-related data on Geron Corp (GERN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- United Natural Foods (UNFI) Tops Q4 EPS by 8c ; Offers Guidance
- UBS upgrades Lockheed Martin to Buy, sees 26% upside on missile growth
- Labcorp acquires MLM Medical Labs to expand lab network
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
